# Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

> **NCT00288587** · PHASE4 · COMPLETED · sponsor: **NxStage Medical** · enrollment: 36 (actual)

## Conditions studied

- Heart Failure
- CHF

## Interventions

- **DRUG:** IV loop diuretic
- **DEVICE:** NxStage System One

## Key facts

- **NCT ID:** NCT00288587
- **Lead sponsor:** NxStage Medical
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2008-09
- **Final completion:** 2009-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288587, "Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00288587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*